Covetrus Celebrates Launch as Newly Formed Public Company

Covetrus (NASDAQ:CVET) celebrates the combination of two unique and complementary businesses – Henry Schein Animal Health and Vets First Choice – as a newly formed company. Covetrus will leverage decades-long experience, insights, technology and global [...]

Teckro raises $25 million Series C financing

Teckro has raised a fresh round of funding to accelerate its aim of helping to bring drugs and treatments to market quicker and more efficiently. The $25 million Series C round was led by Northpond [...]

Adimab Provides 2018 Update on Clinical Pipeline

Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, today announced that 12 new partner programs entered clinical development in 2018. This brings the total number of [...]

FierceBiotech Names Compass Therapeutics a 2018 “Fierce 15” Biotech Company

Compass Therapeutics, a biotechnology company committed to the ambitious goal of comprehensively drugging the human immune system, today announced that it has been named by FierceBiotech as one of 2018’s Fierce 15 biotechnology companies, designating [...]

Jesse Devitte

Contact Us

We’re always interested in engaging with inventors, creators, and entrepreneurs to help develop ideas and realize visions.

icon-phone 603.643.1500

icon-mail investors@borealisventures.com